Inicio
Markets
Charts & Ideas
Algo
Noticias
Store
Corredores
Descargar
Calendario económico
Señales Comerciales
WebTerminal
Pulse
/
para buscar: @user, $symbol, ...
Buscar
Entrada
Crear una cuenta
Español
English
Русский
中文
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
ZNTL
#3078
Zentalis Pharmaceuticals, Inc. Common Stock
2.3
9
-0.42%
Sector:
Básica:
Profit Currency:
Rango diario
Rango anual
Cambio diario
-0.42%
Monthly Change
-18.98%
6 month change
+32.78%
Cambio anual
+17.73%
Cierres anteriores
2.4
0
Open
2.3
9
Bid
Ask
Low
2.3
9
High
2.3
9
Volumen
70
Markets
Acciones
Atención Sanitaria
ZNTL
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Dividends per share
—
—
—
—
—
—
Dividend yield %
—
—
—
—
—
—
Payout ratio %
—
—
—
—
—
—
Noticias
La directora ejecutiva de Zentalis Pharma, Eastland, vende acciones por 21.000 dólares
Zentalis Pharma CEO Eastland sells $21k in shares
El director médico de Zentalis Pharma, Bruns, vende acciones por 7.998 dólares
Zentalis Pharma CMO Bruns sells $7998 in stock
PAO de Zentalis Pharmaceuticals vende acciones por $7.8 mil
Zentalis Pharmaceuticals: Late Stage, Lots Of Cash, Crushed By The Market
Zentalis Pharmaceuticals: Hanging On For One Last Shot At PROC Approval (ZNTL)
Objetivo de precio de Zentalis Pharmaceuticals reducido a 2 dólares en Leerink Partners
Leerink Partners reduce precio objetivo de Zentalis Pharmaceuticals a $2
Zentalis Pharmaceuticals stock price target lowered to $2 at Leerink Partners
Zentalis to present azenosertib data at cancer therapeutics conference
Zentalis Pharmaceuticals shareholders elect three directors at annual meeting